Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies
Malaria, an infection caused by apicomplexan parasites of the genus Plasmodium, continues to exact a significant toll on public health with over 200 million cases world-wide, and annual deaths in excess of 600,000. Considerable progress has been made to reduce malaria burden in endemic countries in...
Үндсэн зохиолчид: | Nacer, A, Kivi, G, Pert, R, Juronen, E, Holenya, P, Aliprandini, E, Amino, R, Silvie, O, Quinkert, D, Le Duff, Y, Hurley, M, Reimer, U, Tover, A, Draper, SJ, Gilbert, S, Ho, MM, Bowyer, PW |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Frontiers Media
2022
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
-н: Adéla Nacer, зэрэг
Хэвлэсэн: (2022-06-01) -
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
-н: Lin Chen, зэрэг
Хэвлэсэн: (2017-02-01) -
The RH5-CyRPA-Ripr complex as a malaria vaccine target
-н: Ragotte, RJ, зэрэг
Хэвлэсэн: (2020) -
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
-н: Paola Favuzza, зэрэг
Хэвлэсэн: (2017-02-01) -
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
-н: Knuepfer, E, зэрэг
Хэвлэсэн: (2019)